• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    OptimizeRx Set to Join S&P SmallCap 600

    9/29/21 6:39:00 PM ET
    $LDL
    $OPRX
    $SPGI
    Auto Parts:O.E.M.
    Capital Goods
    Business Services
    Consumer Discretionary
    Get the next $LDL alert in real time by email

    NEW YORK, Sept. 29, 2021 /PRNewswire/ -- OptimizeRx Corp. (NASD:OPRX) will replace Lydall Inc. (NYSE:LDL) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, October 4. Clearlake Capital Group is acquiring Lydall in a deal that is expected to close on or about October 1.

    Following is a summary of the changes that will take place prior to the open of trading on the effective date:

    Effective Date

    Index Name      

    Action

    Company Name

    Ticker

    GICS Sector

    October 4, 2021

    S&P SmallCap 600

    Addition

    OptimizeRx

    OPRX

    Health Care



    S&P SmallCap 600

    Deletion

    Lydall

    LDL

    Industrials

    For more information about S&P Dow Jones Indices, please visit www.spdji.com

    ABOUT S&P DOW JONES INDICES

    S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

    S&P Dow Jones Indices is a division of S&P Global (NYSE:SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.

    FOR MORE INFORMATION:

    S&P Dow Jones Indices

    [email protected]

    Media Inquiries

    [email protected]

    Cision View original content:https://www.prnewswire.com/news-releases/optimizerx-set-to-join-sp-smallcap-600-301388316.html

    SOURCE S&P Dow Jones Indices

    Get the next $LDL alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $LDL
    $OPRX
    $SPGI

    CompanyDatePrice TargetRatingAnalyst
    S&P Global Inc.
    $SPGI
    4/10/2025$600.00Buy
    BofA Securities
    S&P Global Inc.
    $SPGI
    3/12/2025$599.00Outperform
    Mizuho
    OptimizeRx Corporation
    $OPRX
    1/8/2025$7.00 → $6.00Outperform → Sector Perform
    RBC Capital Mkts
    S&P Global Inc.
    $SPGI
    12/20/2024$600.00Buy
    Citigroup
    OptimizeRx Corporation
    $OPRX
    12/20/2024$5.50Equal-Weight
    Stephens
    S&P Global Inc.
    $SPGI
    10/2/2024$599.00Outperform
    Evercore ISI
    S&P Global Inc.
    $SPGI
    9/23/2024Outperform → Mkt Perform
    Raymond James
    S&P Global Inc.
    $SPGI
    8/13/2024$575.00Overweight
    Wells Fargo
    More analyst ratings

    $LDL
    $OPRX
    $SPGI
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13G/A filed by OptimizeRx Corporation

      SCHEDULE 13G/A - OptimizeRx Corp (0001448431) (Subject)

      7/16/25 11:35:41 AM ET
      $OPRX
      Business Services
      Consumer Discretionary
    • SEC Form 11-K filed by S&P Global Inc.

      11-K - S&P Global Inc. (0000064040) (Filer)

      6/25/25 6:16:08 PM ET
      $SPGI
      Finance: Consumer Services
      Finance
    • OptimizeRx Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - OptimizeRx Corp (0001448431) (Filer)

      6/24/25 7:45:08 AM ET
      $OPRX
      Business Services
      Consumer Discretionary

    $LDL
    $OPRX
    $SPGI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Veracyte Set to Join S&P SmallCap 600

      NEW YORK, July 24, 2025 /PRNewswire/ -- Veracyte Inc. (NASD: VCYT) will replace Triumph Group Inc. (NYSE:TGI) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, July 29. Warburg Pincus LLC and Berkshire Partners LLC will acquire Triumph Group in a deal expected to close soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector July 29, 2025 S&P SmallCap 600 Addition Veracyte VCYT Health Care July 29, 2025 S&P SmallCap 600 Deletion Triumph Group TGI Industrials For more information about S&P Dow Jones Indices,

      7/24/25 5:58:00 PM ET
      $SPGI
      $TGI
      $VCYT
      Finance: Consumer Services
      Finance
      Aerospace
      Industrials
    • Methane Emissions Intensity of Permian Basin Declined by More than Half in Two Years, New S&P Global Commodity Insights Analysis Finds

      New analysis provides the most accurate public, basin-wide estimate of methane emissions for the Permian HOUSTON, July 24, 2025 /PRNewswire/ -- The methane intensity of oil and gas production in the Permian Basin—an area responsible for half of U.S. oil production and one fifth of natural gas—declined by more than 50% during the 2022-2024 period as improved operations, better equipment and the utilization of AI and other advanced technologies led to reductions across all observable plume rates (large and small), according to a new analysis by S&P Global Commodity Insights. The

      7/24/25 7:00:00 AM ET
      $SPGI
      Finance: Consumer Services
      Finance
    • S&P Global and Barclays Partner on a Multi-Year Strategic Agreement

      NEW YORK and LONDON, July 23, 2025 /PRNewswire/ -- S&P Global (NYSE:SPGI) today announced the signing of a new multi-year strategic agreement with Barclays. The mutually beneficial agreement includes access to a comprehensive suite of S&P Global products, data, and solutions, powered by S&P Capital IQ Pro platform, to support Barclays' businesses across its enterprise and help enhance the bank's offerings to its own customers. As part of the agreement, Barclays will contribute its data to S&P Global's cross-asset pricing and valuation services, enhancing accuracy and coverage in bonds, loans, credit and derivative pricing across the liquidity spectrum.

      7/23/25 9:30:00 AM ET
      $SPGI
      Finance: Consumer Services
      Finance

    $LDL
    $OPRX
    $SPGI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BofA Securities resumed coverage on S&P Global with a new price target

      BofA Securities resumed coverage of S&P Global with a rating of Buy and set a new price target of $600.00

      4/10/25 8:19:38 AM ET
      $SPGI
      Finance: Consumer Services
      Finance
    • Mizuho initiated coverage on S&P Global with a new price target

      Mizuho initiated coverage of S&P Global with a rating of Outperform and set a new price target of $599.00

      3/12/25 7:34:28 AM ET
      $SPGI
      Finance: Consumer Services
      Finance
    • OptimizeRx downgraded by RBC Capital Mkts with a new price target

      RBC Capital Mkts downgraded OptimizeRx from Outperform to Sector Perform and set a new price target of $6.00 from $7.00 previously

      1/8/25 8:17:01 AM ET
      $OPRX
      Business Services
      Consumer Discretionary

    $LDL
    $OPRX
    $SPGI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Lang James Paul bought $2,443,761 worth of shares (321,408 units at $7.60), increasing direct ownership by 472% to 389,452 units (SEC Form 4)

      4 - OptimizeRx Corp (0001448431) (Issuer)

      3/19/25 7:40:24 PM ET
      $OPRX
      Business Services
      Consumer Discretionary
    • CEO Febbo William J bought $100,220 worth of shares (20,000 units at $5.01), increasing direct ownership by 3% to 601,253 units (SEC Form 4)

      4 - OptimizeRx Corp (0001448431) (Issuer)

      12/16/24 2:28:39 PM ET
      $OPRX
      Business Services
      Consumer Discretionary
    • Director Jacoby Rebecca bought $8,971 worth of shares (69 units at $130.01), increasing direct ownership by 17% to 469 units (SEC Form 4)

      4 - S&P Global Inc. (0000064040) (Issuer)

      6/17/24 4:04:40 PM ET
      $SPGI
      Finance: Consumer Services
      Finance

    $LDL
    $OPRX
    $SPGI
    Financials

    Live finance-specific insights

    See more
    • S&P Dow Jones Indices to Acquire ARC Research, Expanding Wealth Data and Benchmarking Capabilities

      LONDON, July 21, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI"), a division of S&P Global (NYSE:SPGI) and the world's leading index provider, today announced that it has entered into a definitive agreement to acquire ARC Research, a subsidiary of ARC Group, and the leading independent provider of investment performance data, benchmarking capabilities and insights in the private wealth market. ARC Research maintains the world's largest proprietary dataset of more than 500,000 private client portfolios spanning over two decades. The firm is a trusted partner to more than

      7/21/25 7:00:00 AM ET
      $SPGI
      Finance: Consumer Services
      Finance
    • OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET

      WALTHAM, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, will hold a conference call on Thursday, August 7, 2025, at 4:30 p.m. Eastern Time to discuss its results for the second quarter period ended June 30, 2025. The financial results will be issued in a press release prior to the call. OptimizeRx management will host the call, followed by a question-and-answer period. Details for the conference call can be found below: Date:Thursday, August 7, 2025Time:4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)T

      7/17/25 7:30:00 AM ET
      $OPRX
      Business Services
      Consumer Discretionary
    • S&P Dow Jones Indices Reports U.S. Common Indicated Dividend Payments Increase of $7.4 Billion in Q2 2025 as Dividend Growth Continues to Slow

      Q2 2025 U.S. common dividend increases were $9.8 billion, down 49.8% from $19.5 billion in Q1 2025 and down 52.1% from $20.4 billion in Q2 2024.Q2 2025 U.S. common dividend decreases were $2.3 billion, down 44.0% from $4.2 billion in Q1 2025, and down 46.8% from $4.4 billion in Q2 2024.Q2 2025 net indicated dividend rate change increased $7.4 billion. For the 12-months ending June 2025, U.S. common dividend increases were $57.6 billion down 26.8% from the 12-month June 2024 period's $78.7 billion; decreases were down 43.9% to $13.5 billion compared to $24.1 billion for the prior 12-month period.The net 12-month June 2025 indicated dividend increase was $44.1 billion compared to $54.6 billion

      7/7/25 9:00:00 AM ET
      $SPGI
      Finance: Consumer Services
      Finance

    $LDL
    $OPRX
    $SPGI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Klema Cathy was granted 9,868 shares, increasing direct ownership by 84% to 21,620 units (SEC Form 4)

      4 - OptimizeRx Corp (0001448431) (Issuer)

      6/12/25 4:36:16 PM ET
      $OPRX
      Business Services
      Consumer Discretionary
    • Director Lang James Paul was granted 9,868 shares, increasing direct ownership by 3% to 399,320 units (SEC Form 4)

      4 - OptimizeRx Corp (0001448431) (Issuer)

      6/12/25 4:35:31 PM ET
      $OPRX
      Business Services
      Consumer Discretionary
    • Director Spangler Patrick D was granted 9,868 shares, increasing direct ownership by 22% to 55,335 units (SEC Form 4)

      4 - OptimizeRx Corp (0001448431) (Issuer)

      6/12/25 4:34:57 PM ET
      $OPRX
      Business Services
      Consumer Discretionary

    $LDL
    $OPRX
    $SPGI
    Leadership Updates

    Live Leadership Updates

    See more
    • Veracyte Set to Join S&P SmallCap 600

      NEW YORK, July 24, 2025 /PRNewswire/ -- Veracyte Inc. (NASD: VCYT) will replace Triumph Group Inc. (NYSE:TGI) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, July 29. Warburg Pincus LLC and Berkshire Partners LLC will acquire Triumph Group in a deal expected to close soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector July 29, 2025 S&P SmallCap 600 Addition Veracyte VCYT Health Care July 29, 2025 S&P SmallCap 600 Deletion Triumph Group TGI Industrials For more information about S&P Dow Jones Indices,

      7/24/25 5:58:00 PM ET
      $SPGI
      $TGI
      $VCYT
      Finance: Consumer Services
      Finance
      Aerospace
      Industrials
    • Block Set to Join S&P 500

      NEW YORK, July 18, 2025 /PRNewswire/ -- Block Inc. (NYSE:XYZ) will replace Hess Corp. (NYSE:HES) in the S&P 500 effective prior to the opening of trading on Wednesday, July 23. S&P 500 and S&P 100 constituent Chevron Corp. (NYSE: CVX) has acquired Hess Corp in a deal that closed today, July 18. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name  Action Company Name Ticker GICS Sector July 23, 2025 S&P 500 Addition Block XYZ Financials July 23, 2025 S&P 500 Deletion Hess HES Energy For more information about S&P Dow Jones Indices, please visit www.spdji.com.  ABOUT S&P DOW JONES INDICES S&P Dow Jones Indi

      7/18/25 6:02:00 PM ET
      $CVX
      $HES
      $SPGI
      $XYZ
      Integrated oil Companies
      Energy
      Finance: Consumer Services
      Finance
    • AeroVironment Set to Join S&P MidCap 400; Victory Capital Holdings to Join S&P SmallCap 600

      NEW YORK, July 15, 2025 /PRNewswire/ -- AeroVironment Inc. (NASD: AVAV) will replace ChampionX Corp. (NASD: CHX) in the S&P MidCap 400, and Victory Capital Holdings Inc. (NASD: VCTR) will replace AeroVironment in the S&P SmallCap 600 effective prior to the opening of trading on Friday, July 18. S&P 500 constituent Schlumberger Ltd. (NYSE:SLB) is acquiring ChampionX in a deal expected to be completed July 16, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector July 18, 2025 S&P MidCap 400 Addition AeroVironment AVAV Industrials J

      7/15/25 5:44:00 PM ET
      $AVAV
      $CHX
      $SLB
      $SPGI
      Aerospace
      Industrials
      Industrial Machinery/Components
      Oilfield Services/Equipment

    $LDL
    $OPRX
    $SPGI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by OptimizeRx Corporation

      SC 13G/A - OptimizeRx Corp (0001448431) (Subject)

      12/6/24 4:26:03 PM ET
      $OPRX
      Business Services
      Consumer Discretionary
    • SEC Form SC 13G filed by OptimizeRx Corporation

      SC 13G - OptimizeRx Corp (0001448431) (Subject)

      11/14/24 3:18:35 PM ET
      $OPRX
      Business Services
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by OptimizeRx Corporation

      SC 13G/A - OptimizeRx Corp (0001448431) (Subject)

      11/14/24 11:25:34 AM ET
      $OPRX
      Business Services
      Consumer Discretionary